Characteristic | MDR/XDR-TB cohort (primary) |
---|---|
Female sex — no./total no. (%) | 56/57 (98%) |
Median age (range) — yr | 33 (22–58) |
Time from most recent diagnosis to small hair sample collection (median, IQR) — days | 144 (50–337) |
Drug-resistance status — no./total no. (%) | |
Pre-XDR/XDR-TB | 36/57 (63%) |
MDR-TB | 16/57 (28%) |
Poly-resistance | 1/57 (2%) |
RR-TB | 4/57 (7%) |
Treatment Outcome — no./total no. (%) | |
Loss to follow-up | 14/57 (25%) |
Treatment failure | 6/57 (11%) |
Relapse | 3/57 (5%) |
Continuing Treatment | 18/57 (32%) |
Cure | 15/57 (26%) |
Complete | 1/57 (2%) |